Clinical Trials
16 trialsNCT04996706 2026-05-26
LEO
Mayo Clinic
Enrolling by invitation
NCT06749600 2026-05-05
POLMS
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT05233098 2025-03-06
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Completed
NCT05874921 2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
NCT06788665 2025-01-23
AI-DSII
Vastra Gotaland Region
Not yet recruiting
NCT04005183 2024-10-10
REMEDY
University Health Network, Toronto
Completed
NCT01398306 2024-05-06
BANN
University Medical Center Groningen
Completed
NCT04312737 2023-01-06
EU-VALHUDES
Hiantis Srl
Completed
NCT04949282 2022-12-23
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Recruiting
NCT02861885 2022-03-21
Lesion SSL
Hospices Civils de Lyon
Unknown
NCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT04287335 2020-12-08
CLEAR-C
Zhejiang University
Completed
NCT01339975 2019-08-05
ChemoRenCan
University Hospital, Bordeaux
Completed
NCT02005965 2018-09-18
MERCURY II
Royal Marsden NHS Foundation Trust
Unknown
NCT01995942 2018-09-14
MARVEL
Royal Marsden NHS Foundation Trust
Unknown
NCT01579253 2012-12-18
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
Ludwig-Maximilians - University of Munich
Unknown